Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kim Helen Susan
Relationship:   Director
City:   Hayward
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   591,681    

Indirect Shares

   0      
Direct Value   $155,224    

Indirect Value

   $0      
Total Shares   591,681      
Total Value   $155,224      


ImmunoCellular Therapeutics Ltd $50 Applied Molecular Transport Inc. $155,174 ImmunoCellular Therapeutics Ltd $50 Applied Molecular Transport Inc. $155,174
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            ImmunoCellular Therapeutics Ltd IMUC Director 2012-05-25 1,667 0    Premium*  
            Kite Pharma, Inc. KITE EVP, Business Developm... 2017-10-03 0 2015-12-17 0    Premium*  
            Applied Molecular Transport Inc. AMTI Director 2021-08-25 590,014 2020-07-02 0    Premium*  
* Premium Members only  

Records found :    32         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2015-12-17 4 A $0.00 $0 D/D 9,200 9,200 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2016-08-12 4 OE $51.43 $1,722,905 D/D 33,500 42,500 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2016-08-12 4 AS $60.08 $2,012,596 D/D (33,500) 9,000 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2016-08-15 4 OE $51.43 $123,432 D/D 2,400 11,400 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2016-08-15 4 AS $63.01 $151,229 D/D (2,400) 9,000 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2016-12-20 4 S $50.86 $47,605 D/D (936) 8,064 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2016-12-22 4 A $0.00 $0 D/D 10,600 18,664 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-02-28 4 OE $51.43 $2,503,756 D/D 47,900 66,564 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-02-28 4 AS $63.00 $3,228,372 D/D (47,900) 18,664 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-03-01 4 OE $53.90 $129,360 D/D 2,400 21,064 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-03-01 4 AS $68.95 $181,039 D/D (2,400) 18,664 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-04-03 4 OE $53.90 $129,360 D/D 2,400 21,064 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-04-03 4 S $81.80 $196,320 D/D (2,400) 18,664 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-05-01 4 AS $82.12 $197,088 D/D (2,400) 18,664 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-05-01 4 OE $53.90 $129,360 D/D 2,400 21,064 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-06-01 4 OE $51.43 $123,432 D/D 2,400 21,064 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-06-01 4 AS $72.45 $173,880 D/D (2,400) 18,664 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-07-31 4 OE $51.43 $1,411,437 D/D 26,649 45,313 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-07-31 4 AS $108.75 $2,912,272 D/D (26,649) 18,664 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-08-08 4 OE $53.90 $4,309,251 D/D 79,949 98,613 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-08-08 4 AS $115.02 $9,558,324 D/D (79,949) 18,664 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-08-10 4 AS $120.09 $750,683 D/D (6,251) 18,664 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-08-10 4 OE $51.43 $330,369 D/D 6,251 24,915 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-09-25 4 A $0.00 $0 D/D 6,000 24,864 0 -
KITE Kite Pharma, Inc. EVP, Business Development   •       –      –    2017-09-25 4 S $179.66 $569,714 D/D (3,171) 21,693 0 -
  32  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us